Karolinska Universitetssjukhuset Huddinge

Stockholm, Stockholms Län [se-01] 141 86

0 studies enrolling now · 2 studies all time

What they study most

Multiple Myeloma, Pancreatic Ductal Adenocarcinoma

Studies at this site

• A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30) — Running, not enrolling
• Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant — Running, not enrolling